Actor Russell Crowe recently appeared at the Venice International Film Festival celebrating his son’s birthday, while also drawing attention for his reported 50-pound weight loss — a transformation he says was supported by lifestyle changes and medical wellness treatments that include peptide therapy. The 62-year-old Gladiator ...
Peptide-based drugs are not new, but demand, controversy, and innovation around them are now growing fast again — creating what many describe as a modern “gold rush” in medicine. A quick history of peptide medicines Peptide therapies have been used in medicine for over a century. ...
Samsung Biologics has secured a new $262 million manufacturing contract with a European pharmaceutical company, according to a regulatory filing, as the South Korean firm continues expanding into the fast-growing peptide drug market. The deal will run until the end of 2033, though the identity of ...
Thai authorities have seized illegal weight-loss injection products worth more than 50 million baht from a house in Nonthaburi, where investigators say the seller was making around 8 million baht a month from online sales. The raid took place in Bang Yai district after a parent ...
Scientists have discovered that certain wound-healing peptides could help reduce harmful bacterial buildup in the lungs of people with cystic fibrosis, a genetic disease that causes long-term respiratory infections. The research, led by the University of Geneva (UNIGE), suggests that these peptides may help restore the ...
A new industry report highlights how peptide‑based therapies are beginning to reshape the treatment landscape for Alcohol Use Disorder (AUD). Covering more than 25 companies and investigational drugs, the analysis points to novel CNS pathways, genetically targeted therapies, and long‑acting formulations as the next frontier in ...
Biodexa Pharmaceuticals has reported interim results for the first half of 2026, highlighting progress in its peptide‑derived therapeutic eRapa, now in a registrational Phase 3 trial for Familial Adenomatous Polyposis (FAP). Peptide Innovation in GI Cancer eRapa is a proprietary oral formulation of rapamycin, an mTOR ...
Laboratoire PYC has introduced Blue Cell Elixir, a powdered nutricosmetic that takes aim at one of the biggest challenges in collagen supplementation: bioavailability. Traditional collagen powders often require massive doses — 5,000 to 10,000 mg — because much of the peptide content is broken down in ...
Adneuris Therapeutics presented new findings at PAINWeek 2026 that could mark a turning point in how moderate‑to‑severe acute pain is treated. Their lead candidate, cebranopadol, showed strong efficacy in Phase 3 trials while also demonstrating a meaningfully lower abuse potential compared with traditional opioids like oxycodone. ...
On September 10, SNS Insider reported that the oral GLP‑1 therapeutics market is projected to soar from USD 6.81 billion in 2025 to USD 137.36 billion by 2035, a staggering 35% compound annual growth rate. Overall, this assessment signals a potential shift in how diabetes and ...
On September 24, the 7th Circuit Court of Appeals will hear Eli Lilly v. Robert F. Kennedy, Jr. in what could be the most important legal case for the peptide and compounding industry in years. At stake is not only the future of Eli Lilly’s next‑generation ...
Scientists are developing a new class of medicines called macrocyclic peptides, which may help target diseases that have been difficult to treat with traditional drugs. The research is focused on making large peptide molecules that can behave like both: Small pills (easy to take orally) Antibody ...
